查詢結果分析
相關文獻
- 利用鐳射流體細胞儀回溯研究口腔鱗狀細胞癌之去氧核糖核酸套數
- 口腔鱗狀細胞癌之早期發現--兩病例之報告
- Serum levels of Beta-2 Microglobulin in Patients with Oral Squamous Cell Carcinoma
- ELISA Analysis of Serum VEGF in Oral Squamous Cell Carcinoma Patients
- 全顏面骨骨折合併口腔癌治療--病例報告
- 口腔鱗狀細胞癌合併發生肝細胞癌--病例報告
- 鉈-201單光子電腦斷層造影和電腦斷層攝影(CT)或磁振攝影(MRI)在偵測殘餘或復發性口腔鱗狀細胞癌上的比較
- 成人第二型糖尿病對口腔鱗狀細胞癌預後之影響
- 口腔癌的血小板衍生性生長因子及其受體之基因表現分析
- 多發性口腔癌併腮腺區淋巴結潛伏性轉移--病例報告
頁籤選單縮合
題 名 | Serum levels of Beta-2 Microglobulin in Patients with Oral Squamous Cell Carcinoma=口腔鱗狀細胞癌患者血清中Beta-2 Microglobulin之含量 |
---|---|
作 者 | 林崧池; 韓良俊; | 書刊名 | 中華民國口腔顎面外科學會雜誌 |
卷 期 | 2:2 1991.09[民80.09] |
頁 次 | 頁35-41 |
分類號 | 416.94 |
關鍵詞 | 口腔鱗狀細胞癌; |
語 文 | 英文(English) |
中文摘要 | 以13位健康正常者為控制組,及43位不同臨床期數的口腔鱗狀細胞癌的患者為對象,其中17位是第一期,13位是第二期,9位第三 期,4位第四期,抽其靜脈血,以Phadezyme Beta 2 - Micro Test (Pharmacia Diagnostics Uppsala, Sweden )作酵素間接免疫螢光椅查血清中Beta- 2 Microglobulin (B - MG)含量。結果顯示,口腔鱗狀細胞癌忠者血清中B-MG量比正常健康者高,在各臨床期數之間B-MG之差異並不顯著,無統計學上之差異。由於控制組與腫瘤患者血 清中B-MG量重疊極多,故B-MG作為一腫瘤標誌 (tumor marker) 是不適合的。 |
英文摘要 | Thirteen normal subjects and 43 patients with oral squamous cell carcinoma (17 in stage 1, 13 in stage U, 9 in stage III, 4 in stage IV) were studied to assess the potential abnormality in serum Beta - 2 microglobulin (B - MG) level by using Enzyme Immunoassay with Phadezyme B2 - Micro Test (Pharmacia Diagnostics, Uppsala, Sweden). It was shown that the serum B - MG levels of patients with oral squamous cell carcinoma were significantly elevated when compared with those in the normal subjects, but ther were no significant differences among the different clinical stages. Due to the extensive overlap of values between normal subjects and tumor patients. It was suggested that the serum B - MG level is not a suitable tumor marker for oral squamous cell carcinoma. |
本系統中英文摘要資訊取自各篇刊載內容。